extract from an article on Seeking Alpha
For the pediatric trial, however, there is really nothing left to discuss. The trial was a failure. How much of an effect the pediatric Rett data will have on the rest of the pipeline is anyone's guess, but for now, the stock has taken a terrible beating, going down losing 40% overnight.The company did try to explain the poor show by claiming a very strong placebo effect, but their reasons sounded hollow.
- Forums
- ASX - By Stock
- NEU
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-167
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.34 |
Change
-0.410(2.60%) |
Mkt cap ! $1.960B |
Open | High | Low | Value | Volume |
$15.88 | $15.93 | $15.34 | $6.463M | 415.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 6044 | $15.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.57 | 1411 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1892 | 15.320 |
3 | 2996 | 15.300 |
1 | 1308 | 15.290 |
1 | 300 | 15.280 |
2 | 1892 | 15.270 |
Price($) | Vol. | No. |
---|---|---|
15.570 | 1411 | 2 |
15.620 | 2616 | 3 |
15.660 | 1892 | 1 |
15.680 | 1892 | 1 |
15.710 | 1892 | 1 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online